 |
|
methylmercaptopurine riboside
A purine derivative with antineoplastic and anti-angiogenic properties. 6-methylmercaptopurine riboside (6-MMPR) inhibits amidophosphoribosyltransferase, the first committed step in de novo purine synthesis, and inhibits fibroblast growth factor-2 (FGF2)-induced cell proliferation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonym: | | methylthioinosine | | | | Abbreviations: | | 6-MMPR
MMPR | | | | Code names: | | NCI-C04784
SQ 21977 | | | | Chemical structure names: | | - 6-(methylmercapto)purine ribonucleoside
- 6-(methylthio) inosine
- 6-(methylthio)purine ribonucleoside
- 6-(methylthio)purine riboside
- 6-methyl MP riboside
- 6-methylmercaptopurine riboside
- 6-methylthioinosine
- 9H-purine, 6-(methylthio)-9beta-D-ribofuranosyl
- 9H-purine, 6-(methylthio)-9-beta-D-ribofuranosyl- (8CI 9CI)
- 9H-purine, 6-(methylthio)-9-beta-D-ribofuranosyl-, dihydrate
- beta-D-ribosyl-6-methylthiopurine
- purine-6-thiol,6-methyl-9-ribofuranosyl
| | |
|
|
